Dalfampridine
NDC 82249-702, Dalfampridine, tablet, film coated, extended release, from CivicaScript LLC.
- Product NDC
- 82249-702
- Status
- Listed
- Labeler
- CivicaScript LLC
- Dosage form
- TABLET, FILM COATED, EXTENDED RELEASE
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA206765
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/82249-702 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- DALFAMPRIDINE10 mg/1
Pharmacologic classes
Potassium Channel Antagonists [MoA]; Potassium Channel Blocker [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 82249-702-60 | 82249070260 | 60 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (82249-702-60) |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/c40dcc84-b839-44aa-94f2-886fb1c3d75cNADAC price for package 82249070260
GET /v1/drugs/nadac/82249070260
Use it
Look up 82249-702 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/82249-702 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 82249-702. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.